In exceptional circumstances, it may be considered for people with a BMI of 30-34.9 kg/m with specific risk factors
Post-cholecystectomy patients with reduced GLP-1 receptor sensitivity may need higher final doses or dual-compound options to achieve weight loss goals
Success starts at the store
This biological difference means that the mechanism driving C-cell tumors in rats, chronic GLP-1 receptor stimulation leading to C-cell proliferation, may simply not operate in human thyroid tissue, or at least not at anywhere near the same intensity
11LauterburgBH, CorcoranGB, MitchellJR
This model eliminates insurance gatekeeping entirely, making weight loss treatment accessible to the estimated 27 million American adults without health insurance